Status:
RECRUITING
Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City
Lead Sponsor:
Zhongshan People's Hospital, Guangdong, China
Collaborating Sponsors:
Wuzhou Red Cross Hospital
Xiamen University
Conditions:
Nasopharyngeal Carcinoma
Eligibility:
All Genders
30-69 years
Brief Summary
All participants will be tested for EBV associated biomarkers, including EBNA1-IgA, VCA-IgA, BNLF2b total antibodies (P85-Ab) et al. For all male participants and P85-Ab positive female participants, ...
Detailed Description
Sample selection \- Select communities of 20,000 to 40,000 populations in Zhongshan City and Wuzhou city as the investigators' fields. Participants recruitment * Subjects voluntarily attend this sc...
Eligibility Criteria
Inclusion
- Subject residents in Zhongshan City or Wuzhou City
- Subject has no medical record of nasopharyngeal carcinoma
- ECOG 0-2
- Subject is able to comprehend, sign, and date the written informed consent document to participate in the study.
- Subject has psychical condition and well consciousness, and also accept and cooperate with the follow-up of this study.
Exclusion
- Subject has heavy cardiovascular, liver or kidney disease.
- Subject has contraindications to nasopharyngeal fiberoptic endoscopy.
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
40000 Patients enrolled
Trial Details
Trial ID
NCT04085900
Start Date
April 1 2020
End Date
December 31 2027
Last Update
July 13 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongshan People's Hospital
Zhongshan, Guangdong, China, 528403
2
Wuzhou Red Cross Hospital
Wuzhou, Guangxi, China, 543002